Amy Clifton diagnosed with type 1 narcolepsy after decades

Amy Clifton spent nearly three decades experiencing severe insomnia, nightmares, and debilitating daytime sleepiness before receiving a correct diagnosis of type 1 narcolepsy at age 30, CNN reported. The rare sleep disorder stems from a lack of orexina, a crucial brain chemical that stabilizes sleep and prevents the brain from lingering in an intermediate state between wakefulness and rest.

Decades of Misdiagnoses and Overlooked Symptoms

Beginning at age 4, Clifton struggled with symptoms that were repeatedly attributed to other conditions or behavioral issues. During elementary school, teachers labeled her lazy, while a pediatrician prescribed birth control during her adolescence to manage sleep deprivation, mood changes, and irritability.

Distressing hallucinations involving voices, lights, and figures were dismissed as childhood night terrors. At age 29, following a hospitalization driven by severe mental health distress, specialists diagnosed her with bipolar disorder type II and prescribed medications that made her feel like a zombie without alleviating her symptoms.

While the moment later became a running joke at parties, it stemmed from hypnagogic hallucinations—a hallmark sign of type 1 narcolepsy that causes Clifton to experience visions nearly every night.

Cataplexy and the Daily Toll of Type 1 Narcolepsy

Clifton also experiences partial cataplexy, a condition where intense emotions cause sudden muscle weakness. Loud noises could temporarily paralyze her body, and laughter caused her head to drop forward and her knees to buckle.

Clifton and her husband eventually had a daughter, who now exhibits classic signs of partial cataplexy at age 9, followed by twins.

Dr. Shelby Harris, a certified sleep medicine psychologist and clinical associate professor at the Albert Einstein College of Medicine in the Bronx, noted that type 1 narcolepsy is frequently misunderstood. The people think that something is wrong with you. That you can’t be counted on. That you can’t function in society, Harris stated.

The Search for Treatment and Insurance Obstacles

A breakthrough arrived when a doctor reviewed Clifton’s sleep history and connected her hallucinations and sudden knee weakness to type 1 narcolepsy.

Dr. Aubrey Kuehnel, Clifton’s current sleep specialist and a neurologist at University of Michigan Health-West, explained that insurers require extensive sleep studies or a lumbar puncture to approve the drug, which can cost more than US$ 12,000 monthly. An insurance company denied coverage after construction noise disrupted one of Clifton’s sleep tests, preventing her from entering REM sleep quickly enough to meet diagnostic criteria.

While an appeal remains pending with the insurer, Clifton’s physician enrolled her in a manufacturer patient assistance program that supplies the medication for free through the end of the year. The treatment comes as Clifton continues to manage severe symptoms, including recent vivid hallucinations that prompted her to wake her husband in terror.